Literature DB >> 24577390

Trial watch: global migration of clinical trials.

Paul K Drain1, Marion Robine2, King K Holmes3, Ingrid V Bassett4.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24577390      PMCID： PMC4006355          DOI： 10.1038/nrd4260

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  16 in total

1.  Health professionals for a new century: transforming education to strengthen health systems in an interdependent world.

Authors:  Julio Frenk; Lincoln Chen; Zulfiqar A Bhutta; Jordan Cohen; Nigel Crisp; Timothy Evans; Harvey Fineberg; Patricia Garcia; Yang Ke; Patrick Kelley; Barry Kistnasamy; Afaf Meleis; David Naylor; Ariel Pablos-Mendez; Srinath Reddy; Susan Scrimshaw; Jaime Sepulveda; David Serwadda; Huda Zurayk
Journal:  Lancet       Date:  2010-11-26       Impact factor: 79.321

2.  Global cardiovascular disease research survey.

Authors:  Poornima Prabhakaran; Vamadevan S Ajay; Dorairaj Prabhakaran; Arun Kumar Gottumukkala; J S Shrihari; Uma Snehi; Bijoy Joseph; Kolli Srinath Reddy
Journal:  J Am Coll Cardiol       Date:  2007-11-26       Impact factor: 24.094

3.  Clinical trial registration: looking back and moving ahead.

Authors:  Christine Laine; Richard Horton; Catherine D DeAngelis; Jeffrey M Drazen; Frank A Frizelle; Fiona Godlee; Charlotte Haug; Paul C Hébert; Sheldon Kotzin; Ana Marusic; Peush Sahni; Torben V Schroeder; Harold C Sox; Martin B Van der Weyden; Freek W A Verheugt
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

Review 4.  Conduct of clinical trials in developing countries: a perspective.

Authors:  Niveditha Devasenapathy; Kavita Singh; Dorairaj Prabhakaran
Journal:  Curr Opin Cardiol       Date:  2009-07       Impact factor: 2.161

5.  Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.

Authors:  Robert M Califf; Deborah A Zarin; Judith M Kramer; Rachel E Sherman; Laura H Aberle; Asba Tasneem
Journal:  JAMA       Date:  2012-05-02       Impact factor: 56.272

6.  Roadblocks in HIV research: five questions.

Authors:  Clare Thomas
Journal:  Nat Med       Date:  2009-08       Impact factor: 53.440

Review 7.  Lessons from 60 years of pharmaceutical innovation.

Authors:  Bernard Munos
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

8.  Funding of US biomedical research, 2003-2008.

Authors:  E Ray Dorsey; Jason de Roulet; Joel P Thompson; Jason I Reminick; Ashley Thai; Zachary White-Stellato; Christopher A Beck; Benjamin P George; Hamilton Moses
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

9.  Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis.

Authors:  Joseph S Ross; Tony Tse; Deborah A Zarin; Hui Xu; Lei Zhou; Harlan M Krumholz
Journal:  BMJ       Date:  2012-01-03

10.  The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries.

Authors:  Lydia Kapiriri; James V Lavery; Peter A Singer; Hassan Mshinda; Lorne Babiuk; Abdallah S Daar
Journal:  BMC Public Health       Date:  2011-10-18       Impact factor: 3.295
View more
  22 in total

Review 1.  Scientific considerations for global drug development.

Authors:  Jennifer L Wilson; Kit Wun Kathy Cheung; Lawrence Lin; Elizabeth A E Green; Analia I Porrás; Ling Zou; David Mukanga; Paul A Akpa; Delese Mimi Darko; Rae Yuan; Sheng Ding; Wiltshire C N Johnson; Howard A Lee; Emer Cooke; Carl C Peck; Steven E Kern; Dan Hartman; Yoshikazu Hayashi; Peter W Marks; Russ B Altman; Murray M Lumpkin; Kathleen M Giacomini; Terrence F Blaschke
Journal:  Sci Transl Med       Date:  2020-07-29       Impact factor: 17.956

Review 2.  Vaccine development and trials in low and lower-middle income countries: Key issues, advances and future opportunities.

Authors:  Amy Grenham; Tonya Villafana
Journal:  Hum Vaccin Immunother       Date:  2017-09-02       Impact factor: 3.452

3.  Racial and Ethnic Composition of Cancer Clinical Drug Trials: How Diverse Are We?

Authors:  Leslie J Dickmann; Jennifer L Schutzman
Journal:  Oncologist       Date:  2017-12-19

4.  Ethical Issues in Conducting Cross-Cultural Research in Low-Income Countries: A Pakistani Perspective.

Authors:  Asma Fazal
Journal:  Asian Bioeth Rev       Date:  2021-11-06

5.  Quantifying geographical accessibility to cancer clinical trials in different income landscapes.

Authors:  G Tini; D Trapani; B A Duso; P Beria; G Curigliano; P G Pelicci; L Mazzarella
Journal:  ESMO Open       Date:  2022-06-21

6.  The patient's safety and access to experimental drugs after the termination of clinical trials: regulations and trends.

Authors:  Ricardo Eccard da Silva; Angélica Amorim Amato; Thiago do Rego Sousa; Marta Rodrigues de Carvalho; Maria Rita Carvalho Garbi Novaes
Journal:  Eur J Clin Pharmacol       Date:  2018-05-12       Impact factor: 2.953

Review 7.  The Future of Clinical Trial Design in Oncology.

Authors:  Anna Spreafico; Aaron R Hansen; Albiruni R Abdul Razak; Philippe L Bedard; Lillian L Siu
Journal:  Cancer Discov       Date:  2021-04       Impact factor: 38.272

8.  Development in the number of clinical trial applications in Western Europe from 2007 to 2015: retrospective study of data from national competent authorities.

Authors:  Tilde Dombernowsky; Merete Hædersdal; Ulrik Lassen; Simon Francis Thomsen
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

9.  Differential Globalization of Industry- and Non-Industry-Sponsored Clinical Trials.

Authors:  Ignacio Atal; Ludovic Trinquart; Raphaël Porcher; Philippe Ravaud
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

10.  Knowledge and Perception about Clinical Research Shapes Behavior: Face to Face Survey in Korean General Public.

Authors:  Yun Jung Choi; Sung-Ho Beck; Woon Yong Kang; Soyoung Yoo; Seong-Yoon Kim; Ji Sung Lee; Tal Burt; Tae Won Kim
Journal:  J Korean Med Sci       Date:  2016-03-15       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.